Chronic morphine sensitizes the brain norepinephrine system to corticotropin-releasing factor and stress

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Guangping XuR J Valentino

Abstract

Chronic opiate use produces persistent changes in brain neurons that are expressed as adverse effects, including physical dependence and compulsive drug-seeking behavior. Dysregulation of the hypothalamic-pituitary-adrenal response to stress also occurs with chronic opiate administration and has been implicated as a contributing factor to continued substance abuse. This study provides the first evidence for dysregulation of the central noradrenergic response to stress by chronic opiates. Chronic morphine selectively sensitized locus ceruleus (LC)-norepinephrine (NE) neurons to corticotropin-releasing factor (CRF), an integral mediator of the stress response. CRF doses that were inactive in vehicle-treated rats produced a near-maximal activation of LC neurons of rats chronically administered morphine. LC sensitization to CRF was not solely a pharmacological phenomenon but was expressed as hyperresponsivity to physiological stress. Finally, opiate-induced LC sensitization translated to a change in the behavioral repertoire in response to environmental stress (swim stress) such that NE-mediated hyperactive behaviors predominated. The opiate-induced sensitization of the central NE response to stress predicts that chronic opiate adm...Continue Reading

Citations

Nov 5, 2005·Brain Research. Brain Research Reviews·Adrie W Bruijnzeel, Mark S Gold
Sep 29, 2005·Behavioral Neuroscience·Kate E BlatchfordGavan P McNally
May 11, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Nayla N ChaijaleRita J Valentino
Jun 20, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Arati KreibichRita J Valentino
Dec 17, 2005·Proceedings of the National Academy of Sciences of the United States of America·Benjamin BoutrelLuis de Lecea
Feb 8, 2008·European Journal of Pharmacology·Rita J Valentino, Elisabeth Van Bockstaele
Apr 25, 2006·The European Journal of Neuroscience·Beverly A S ReyesElisabeth J Van Bockstaele
Jul 6, 2006·The European Journal of Neuroscience·Beverly A S ReyesElisabeth J Van Bockstaele
Feb 28, 2009·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Jillian L Scavone, Elisabeth J Van Bockstaele
Sep 20, 2006·Progress in Neurobiology·Norman PecoraroSusan F Akana
Jul 26, 2005·Peptides·Richard J Bodnar, Gad E Klein
Dec 17, 2014·Neurobiology of Stress·Rita J Valentino, Elisabeth Van Bockstaele
Dec 18, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Kellie M JaremkoElisabeth J Van Bockstaele
Jul 2, 2008·Proceedings of the National Academy of Sciences of the United States of America·Raúl PastorTamara J Phillips
Mar 14, 2017·ACS Chemical Neuroscience·Kathryn G CommonsDaniel G Ehlinger
Nov 5, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Brooke E SchmeichelLeandro F Vendruscolo
Nov 7, 2018·Clinical Obstetrics and Gynecology·Tarek Toubia, Tarek Khalife
Apr 3, 2008·The Journal of Comparative Neurology·B A S ReyesE J Van Bockstaele
Feb 9, 2007·Journal of Neurochemistry·Cristina NunezKrisztina J Kovács
Feb 16, 2019·Brain Structure & Function·Beverly A S ReyesElisabeth J Van Bockstaele
Aug 1, 2018·Neuroscience·Kristofer W LoerwaldMichael P Kilgard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.